A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart disease, say
Scientists from the University of Copenhagen have detected lipid biomarkers in children and teenagers with obesity that indicate an increased risk of developing type 2 diabetes, liver and heart disease
Mount Sinai researchers have published a study that shows a link between prediabetes among young people and adverse pregnancy outcomes later in life. The findings, published in JAMA Network Open
A team of medical researchers affiliated with a large number of institutions in China has functionally cured a female patient with type 1 diabetes by injecting her with programmed stem
GLP1RA agonists have been increasing in popularity for treating obesity and type 2 diabetes. With this novel treatment proving to be very effective, researchers are curious to know more about
Impact of T1D on plasma glucose and pancreatic insulin and glucagon contents in NOD mice. Credit: Nature Metabolism (2024). DOI: 10.1038/s42255-024-01139-z Inhibiting the hormone somatostatin may be a new treatment
Encapsulated glucagon for insulin-induced hypoglycemia dissolves when sugar levels get seriously low (less than 60 milligrams per deciliter, mg/dL), releasing the hormone into the bloodstream and triggering the liver to
Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse
PTX3 is increased in diabetic retinas. Credit: Proceedings of the National Academy of Sciences (2024). DOI: 10.1073/pnas.2320034121 A study published in Proceedings of the National Academy of Sciences details the
Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously difficult to treat.
